What is a recommended taper schedule for a patient taking Effexor (venlafaxine) 75mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effexor (Venlafaxine) 75mg Tapering Schedule

For a patient on Effexor 75mg, a hyperbolic tapering approach with a 10% reduction of the most recent dose per month is recommended to minimize withdrawal symptoms and reduce the risk of relapse. 1

Recommended Tapering Schedule for Venlafaxine 75mg

Initial Approach

  • Start with a 10% reduction of the original dose (75mg) = approximately 67.5mg daily for the first month 1
  • Continue with 10% reductions of each new dose:
    • Month 1: 67.5mg daily
    • Month 2: 60.8mg daily
    • Month 3: 54.7mg daily
    • Month 4: 49.2mg daily
    • Month 5: 44.3mg daily
    • Month 6: 39.9mg daily

Final Tapering Phase

  • As the dose gets smaller, the reductions become smaller (hyperbolic tapering)
  • For the final stages, consider taking the medication every other day before complete discontinuation 1, 2
  • The final doses before complete cessation may need to be very small to prevent a large decrease in neurotransmitter effects when stopped 3

Monitoring and Management

Follow-up Schedule

  • Schedule follow-up visits at least monthly during the tapering process 1
  • Consider more frequent follow-ups (every 2 weeks) if withdrawal symptoms emerge 1

Potential Withdrawal Symptoms

  • Monitor for both somatic and psychological symptoms:
    • Somatic: dizziness, light-headedness, nausea, fatigue, flu-like symptoms, sensory disturbances, sleep problems 4
    • Psychological: anxiety, agitation, crying spells, irritability 4

Managing Withdrawal Symptoms

  • If significant withdrawal symptoms occur:
    • Pause the taper at the current dose
    • Wait 1-2 weeks for symptoms to stabilize
    • Resume tapering at a slower rate (5% reduction instead of 10%) 1

Special Considerations

  • Venlafaxine has a shorter half-life compared to other antidepressants, making it more prone to withdrawal symptoms 4
  • Cardiac conduction abnormalities have been reported with venlafaxine, so monitor patients with cardiac disease closely during tapering 5
  • Consider incorporating cognitive behavioral therapy, stress management techniques, and sleep hygiene practices during tapering to increase success 1

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation: This can lead to severe withdrawal symptoms and increased risk of relapse 4
  • Avoid tapering too quickly: Standard guidelines often recommend short tapers of 2-4 weeks, but these show minimal benefits over abrupt discontinuation and are often not tolerated well 2
  • Don't mistake withdrawal symptoms for recurrence: Withdrawal symptoms can be mistaken for relapse into depression, leading to unnecessary resumption of medication 4
  • Don't use a linear taper: A hyperbolic tapering approach (reducing by smaller amounts as the dose gets lower) is more effective than linear tapering 1, 2

Remember that tapering strips (if available) can facilitate this process by providing gradually decreasing doses in a controlled manner, with studies showing 72% success rates for antidepressant discontinuation 6.

References

Guideline

Discontinuing Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.